Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Not listed Phase 3 Interventional

Transoral Gastroplasty for the Treatment of Morbid Obesity

ClinicalTrials.gov ID: NCT00661245

Public ClinicalTrials.gov record NCT00661245. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 26, 2026, 1:34 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The TOGA® trial is a prospective, multi-center, randomized sham-controlled trial designed to determine the safety and effectiveness of the TOGA System for the treatment of morbid obesity. The study will also determine the effect of the treatment on co-morbidities and quality of life. Subjects will be blinded to treatment or sham. Sham arm may crossover to TOGA treatment at 12 months.

Study identification

NCT ID
NCT00661245
Recruitment status
Not listed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Satiety, Inc.
Industry
Enrollment
275 participants

Conditions and interventions

Conditions

Interventions

Device

Eligibility (public fields only)

Age range
18 Years to 60 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 30, 2008
Primary completion
Sep 30, 2010
Completion
Not listed
Last update posted
May 4, 2009

Started 2008

United States locations

U.S. sites
10
U.S. states
7
U.S. cities
10
Facility City State ZIP Site status
Cedars-Sinai Medical Center Los Angeles California 90048 —
University of California, San Francisco San Francisco California 94110 —
UMass Memorial Medical Center (University of Massachusetts) Worcester Massachusetts 01655 —
University of Minnesota Medical Center Minneapolis Minnesota 55455 —
University of Missouri Health Care Columbia Missouri 65212 —
Washington University in St. Louis - School of Medicine St Louis Missouri 63110 —
Columbia University Medical Center New York New York 10032 —
University Hospitals Geauga Medical Center Chardon Ohio 44024 —
University Hospitals Case Medical Center Cleveland Ohio 44106 —
University of Texas Medical School at Houston Houston Texas 77056 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00661245, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 4, 2009 · Synced Sep 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00661245 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →